TCL Archive Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says September 26, 2014
TCL Archive House Panel Provides NCI $1.7 Billion for 1991, Expects Greater Emphasis On Cancer Prevention July 20, 1990